Self-service tumor-marker-crowd intelligent detection device and method

A tumor marker and intelligent detection technology is applied in the field of self-service tumor marker group intelligent detection devices, which can solve the problems of inconvenience for patients and burden on patients' families, and achieve the effect of improving the accuracy rate

CN106846644AActive Publication Date: 2017-06-13孙翠敏
5 Cites 9 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Publication Date
2017-06-13

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to a self-service tumor-marker-crowd intelligent detection device. The self-service tumor-marker-crowd intelligent detection device comprises a micro-fluidic chip, a chip reader, a mobile phone APP and an intelligent online detection platform, wherein the micro-fluidic chip carries out pain-free fingertip blood collection through an MEMS micro-needle array; the chip reader is used for containing the micro-fluidic chip and a mobile phone; the mobile phone APP obtains gray values of visible light bands, then the gray values are converted into numerical values of all tumor markers, the numerical values and relevant information of detected persons are transmitted to the intelligent online detection platform together, and cancer risk assessment reports and doctor seeing proposals are obtained from the intelligent online detection platform; the intelligent online detection platform carries out cancer risk assessment on the detected persons, gives hospital doctor seeing proposals, and feeds back the hospital doctor seeing proposals to the mobile phone APP. The invention also discloses an intelligent detection method of the self-service tumor-marker-crowd intelligent detection device. By means of the self-service tumor-marker-crowd intelligent detection device and the intelligent detection method, self-service detection can be achieved, only a drop of fingertip blood is required, blood sampling is free of pain through the MEMS micro-needle array, detection data collection and result analysis are automatically carried out through the mobile phone APP, and further doctor seeing proposals are provided.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to the technical field of tumor marker screening, in particular to a self-service intelligent detection device and method for tumor marker groups. Background technique

[0002] The incidence of malignant tumors in our country is increasing day by day, seriously threatening people's health. The best countermeasure to deal with the threat of tumor is "early detection and early treatment". "Early detection" is the premise of "early treatment", which will greatly improve the cure rate and save a lot of medical expenses for patients and society. Tumor screening is an important way to detect cancer and precancerous lesions in the early stage. The popularization and popularization of tumor screening and the improvement of early diagnosis rate are the main effective means of diagnosis and treatment of malignant tumors.

[0003] Tumor screening methods are mainly conventional medical methods, such as medical imaging and other body flui...

Examples

Embodiment Construction

[0032] A self-service intelligent detection device for tumor marker groups, comprising:

[0033] The microfluidic chip uses MEMS microneedle arrays for painless fingertip blood collection, and the fingertip blood reacts with the solid antibody reagent on the microfluidic chip to display visible light bands;

[0034] The chip reader is used to place the microfluidic chip and the mobile phone, so that the mobile phone can take clear pictures of the strips on the microfluidic chip after reaction;

[0035]The mobile phone APP, after a specific time delay, automatically takes pictures of the visible light strips on the microfluidic chip after the reaction, obtains the gray value of the visible light strips, and then converts them into the values ​​of each tumor marker, which is related to the tester. The information is transmitted to the online intelligent detection platform together, and the cancer risk assessment report and medical advice are obtained from the online intelligent ...